SCHEMBL26059907

SCHEMBL26059907

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5c6c7ccccc7n(-c7nc(-c8ccccc8)nc(-c8ccccc8)n7)c6ccc54)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.47
MEN1 O00255 9/20 0.47
MAPT P10636 9/20 0.47
HPGD P15428 9/20 0.47
ALDH1A1 P00352 8/20 0.47
NTSR1 P30989 1/20 0.43
KDM4E B2RXH2 6/20 0.42
LMNA P02545 2/20 0.42
GLA P06280 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.39
ATM Q13315 1/20 0.39
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
NPSR1 Q6W5P4 3/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
PTK2B Q14289 1/20 0.36
MAPK1 P28482 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152205 1.00 KMT2A (0.47) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL26057989 0.99 KMT2A (0.46) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL26057407 0.99 KMT2A (0.46) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL20152167 0.99 MAPT (0.46) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL26057385 0.99 KMT2A (0.46) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL26059912 0.99 KMT2A (0.46) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL23598396 0.97 KMT2A (0.47) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL20152232 0.97 MAPT (0.43) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL23598393 0.97 KMT2A (0.47) KMT2AMEN1MAPTHPGDALDH1A1
SCHEMBL23263007 0.96 KMT2A (0.50) KMT2AMEN1MAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363190-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-11-09 US disclosed
US-20230363190-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-11-09 US disclosed
US-20230276704-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-08-31 US disclosed
US-20230276704-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276704-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT ETV6, IKZF2, EML4 KMT2A 1317/4885MEN1 2733/4885MAPT 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.